Mereo Biopharma Group Plc ADR (MREO) with a beta value of 0.50 appears to be a promising investment opportunity.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) on Tuesday, plunged -8.63% from the previous trading day, before settling in for the closing price of $2.55.